GleamWall
中文EN

GRDN Guardian Pharmacy Services, Inc.

Retail-Drug Stores and Proprietary Stores · NYSE · SEC CIK 1802255 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY4.9%
TTM net income YoY85.8%
TTM EPS YoY84.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin22.4%
Operating margin6.5%
Net margin5.1%
FCF margin—
EBITDA margin8.1%

Returns

ROE33.2%
ROA17.0%
ROIC (approx.)46.2%
Asset turnover3.30x

Leverage & solvency

Liabilities / assets43.1%
Debt / equity0.00x
Current ratio1.65x
Interest coverage145.28x

Cash quality & payout

Operating cash flow / net income1.53x
Accruals ratio-8.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$371.07M$351.77M$336.60M$397.62M$377.43M$344.33M$329.31M$338.57M
Cost of revenue$285.85M$271.72M$260.29M$312.11M$302.71M$276.19M$264.96M$271.46M
Gross profit$85.22M$80.04M$76.31M$85.50M$74.72M$68.15M$64.35M$67.10M
SG&A expense$60.16M$59.40M$58.63M$54.74M$58.37M$55.57M$51.34M$50.35M
Operating income$25.06M$20.64M$17.68M$30.76M$16.35M$12.58M$13.01M$16.75M
Interest expense$177,000$154,000$154,000$163,000$160,000$172,000$170,000$421,000
Pretax income$25.98M$29.79M$18.29M$31.10M$16.63M$12.59M$13.11M$16.22M
Income tax$6.86M$7.67M$4.75M$9.83M$7.04M$3.76M$3.83M$4.38M
Net income$18.68M$21.87M$13.29M$20.92M$9.82M$9.03M$9.45M$11.94M
EBITDA$31.00M$26.45M$23.65M$36.50M$22.19M$18.07M$18.27M$21.91M
EPS (basic)0.29———0.16———
EPS (diluted)0.29———0.15———
Weighted avg. shares (diluted)63.92M———63.43M———
Balance sheet
Cash & equivalents$119.66M$89.81M$64.89M$65.62M$36.49M$18.82M$14.00M$4.66M
Receivables$107.68M$103.77M$111.70M$101.61M$106.19M$94.12M$97.41M$97.15M
Inventory$57.05M$50.44M$47.16M$43.36M$47.86M$44.16M$43.43M$40.55M
Current assets$294.82M$254.67M$235.18M$221.63M$198.28M$170.46M$166.04M$151.99M
PP&E, net$57.42M$56.53M$56.62M$55.52M$56.12M$54.43M$51.47M$49.88M
Goodwill$81.95M$79.74M$79.74M$79.74M$79.57M$76.16M$69.30M$69.30M
Intangibles$20.84M$16.62M$17.48M$18.48M$18.91M$17.59M$14.08M$14.91M
Total assets$491.78M$443.58M$426.94M$412.66M$390.04M$356.33M$334.00M$320.81M
Current liabilities$179.09M$154.04M$160.54M$160.70M$161.95M$143.99M$145.30M$144.12M
Long-term debt———$0———$0
Total debt———$0———$0
Total liabilities$212.06M$185.94M$194.52M$194.73M$194.54M$176.66M$170.78M$170.83M
Shareholders' equity$267.24M$245.61M$220.89M$205.76M$183.76M$169.56M$156.09M$142.67M
Net debt———-$65.62M———-$4.66M
Cash flow statement
Operating cash flow$43.37M$30.02M$6.06M$34.60M$28.17M$19.94M$17.55M$22.34M
Capital expenditure———$495,000$4.00M——$2.25M
Free cash flow———$34.10M$24.17M——$20.09M
Investing cash flow-$10.90M-$4.31M-$4.75M-$4.71M-$8.97M-$13.00M-$5.54M-$6.62M
Financing cash flow-$2.62M-$805,000-$2.04M-$758,000-$1.53M-$2.11M-$2.67M-$48.27M
Depreciation & amortization$5.93M$5.81M$5.98M$5.74M$5.84M$5.49M$5.27M$5.15M
Stock-based compensation$2.73M$2.93M$1.86M$1.08M$4.36M$4.45M$3.97M$3.46M
Share buybacks————$0———

Free plan shows the latest 8 periods; Pro shows all 12 🔒

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.